Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Error recovery by dialysis technicians.

Wilkinson WE, Cauble LA, Patel VL.

Nephrol Nurs J. 2014 Jan-Feb;41(1):41-50; quiz 51.

PMID:
24689264
2.

Error detection and recovery in dialysis nursing.

Wilkinson WE, Cauble LA, Patel VL.

J Patient Saf. 2011 Dec;7(4):213-23. doi: 10.1097/PTS.0b013e3182388d20.

PMID:
22064625
3.
4.

Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures.

Weinberg JB, Lang T, Wilkinson WE, Pisetsky DS, St Clair EW.

Arthritis Res Ther. 2006;8(5):R140.

5.

Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.

Kerr CR, Connolly SJ, Kowey P, Page RL, Pritchett EL, Ruda MY, Ruzyllo W, Wilkinson WE; A-STAR Investigators.

Am J Cardiol. 2006 Jul 15;98(2):215-8. Epub 2006 May 19.

PMID:
16828595
6.

Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.

Pritchett EL, Kowey P, Connolly S, Page RL, Kerr C, Wilkinson WE; A-COMET-I Investigators.

Am Heart J. 2006 May;151(5):1043-9.

PMID:
16644334
7.

Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis.

Anderson DJ, Goldstein LB, Wilkinson WE, Corey GR, Cabell CH, Sanders LL, Sexton DJ.

Neurology. 2003 Nov 25;61(10):1341-6.

PMID:
14638952
8.

Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.

Connolly SJ, Schnell DJ, Page RL, Wilkinson WE, Marcello SR, Pritchett EL; Azimilide Supraventricular Arrhythmia Program Investigators.

Am Heart J. 2003 Sep;146(3):489-93.

PMID:
12947368
9.

Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide.

Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL; Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators.

Circulation. 2003 Mar 4;107(8):1141-5.

PMID:
12615792
10.

An examination of factors predicting prioritization for liver transplantation.

Muir AJ, Sanders LL, Heneghan MA, Kuo PC, Wilkinson WE, Provenzale D.

Liver Transpl. 2002 Oct;8(10):957-61.

11.

Risk factors for positive minor salivary gland biopsy findings in Sjögren's syndrome and dry mouth patients.

Brennan MT, Sankar V, Leakan RA, Kleiner D, Atkinson JC, Wilkinson WE, Baum BJ, Pillemer SR.

Arthritis Rheum. 2002 Apr 15;47(2):189-95.

PMID:
11954013
12.

Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.

Pritchett EL, Schulte MC, Schnell D, Marcello SR, Wilkinson WE, Page RL, Connolly SJ; Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.

J Clin Pharmacol. 2002 Apr;42(4):388-94.

PMID:
11936563
13.

Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.

Page RL, Connolly SJ, Wilkinson WE, Marcello SR, Schnell DJ, Pritchett EL; Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators.

Am Heart J. 2002 Apr;143(4):643-9.

PMID:
11923801
14.

Training physicians for careers in clinical research: a tailored educational experience.

Wilkinson WE, Oddone EZ.

Nat Biotechnol. 2002 Jan;20(1):99-100. No abstract available.

PMID:
11753374
15.

Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.

Connolly SJ, Schnell DJ, Page RL, Wilkinson WE, Marcello SR, Pritchett EL.

Am J Cardiol. 2001 Nov 1;88(9):974-9.

PMID:
11703992
16.

The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.

St Clair EW, Wilkinson WE, Pisetsky DS, Sexton DJ, Drew R, Kraus VB, Greenwald RA.

Arthritis Rheum. 2001 May;44(5):1043-7.

17.

Reducing medication regimen complexity: a controlled trial.

Muir AJ, Sanders LL, Wilkinson WE, Schmader K.

J Gen Intern Med. 2001 Feb;16(2):77-82.

18.

Modeling recurrent arrhythmias.

Pritchett EL, Wilkinson WE.

J Cardiovasc Electrophysiol. 2001 Feb;12(2):131-3. No abstract available.

PMID:
11232607
19.

Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.

Pritchett EL, Page RL, Connolly SJ, Marcello SR, Schnell DJ, Wilkinson WE.

J Am Coll Cardiol. 2000 Sep;36(3):794-802.

20.

Observations on the transition from intermittent to permanent atrial fibrillation.

Al-Khatib SM, Wilkinson WE, Sanders LL, McCarthy EA, Pritchett EL.

Am Heart J. 2000 Jul;140(1):142-5.

PMID:
10874276
21.

Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

Markert ML, Hicks CB, Bartlett JA, Harmon JL, Hale LP, Greenberg ML, Ferrari G, Ottinger J, Boeck A, Kloster AL, McLaughlin TM, Bleich KB, Ungerleider RM, Lyerly HK, Wilkinson WE, Rousseau FS, Heath-Chiozzi ME, Leonard JM, Haase AT, Shaw GM, Bucy RP, Douek DC, Koup RA, Haynes BF, Bolognesi DP, Weinhold KJ.

AIDS Res Hum Retroviruses. 2000 Mar 20;16(5):403-13.

PMID:
10772526
22.

The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ.

Infect Control Hosp Epidemiol. 1999 Nov;20(11):725-30.

PMID:
10580621
23.

Effect of dofetilide on survival in patients with supraventricular arrhythmias.

Pritchett EL, Wilkinson WE.

Am Heart J. 1999 Nov;138(5 Pt 1):994-7.

PMID:
10539835
24.

A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.

St Clair EW, Moak SA, Wilkinson WE, Sanders L, Lang T, Greenwald RA.

J Rheumatol. 1998 Aug;25(8):1472-9.

PMID:
9712086
25.

Initial experience with a high-impedance tined endocardial pacemaker lead: evidence for increased lead failure.

Joglar JA, Welch PJ, Wilkinson WE, Hamdan MH, Page RL.

Am Heart J. 1997 Aug;134(2 Pt 1):161-4.

PMID:
9313592
26.

Evaluation of the effect of transthoracic cardioversion from ventricular tachycardia to sinus rhythm on left atrial mechanical function.

Dodds GA 3rd, Wilkinson WE, Greenfield RA, Natale A, Kisslo J, Pritchett EL.

Am J Cardiol. 1996 Dec 15;78(12):1436-9.

PMID:
8970423
27.

Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients.

St Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS, Pisetsky DS, Granger DI, Weinberg JB.

J Exp Med. 1996 Sep 1;184(3):1173-8.

28.

Heart rate during spontaneous and induced paroxysmal supraventricular tachycardia.

Hamer ME, Wilkinson WE, McCarthy EA, Page RL, Pritchett EL.

Pacing Clin Electrophysiol. 1995 Dec;18(12 Pt 1):2155-7.

PMID:
8771127
29.

Shoulder range of motion in patients with osteoporosis.

Pearlmutter LL, Bode BY, Wilkinson WE, Maricic MJ.

Arthritis Care Res. 1995 Sep;8(3):194-8.

PMID:
7654805
30.

Therapeutic delay and mortality in cases of Rocky Mountain spotted fever.

Kirkland KB, Wilkinson WE, Sexton DJ.

Clin Infect Dis. 1995 May;20(5):1118-21.

PMID:
7619985
31.

Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia.

Hamer ME, Wilkinson WE, Clair WK, Page RL, McCarthy EA, Pritchett EL.

J Am Coll Cardiol. 1995 Apr;25(5):984-8.

32.

Magnetic resonance imaging of the corpus callosum: predictors of size in normal adults.

Parashos IA, Wilkinson WE, Coffey CE.

J Neuropsychiatry Clin Neurosci. 1995 Winter;7(1):35-41.

PMID:
7711489
34.

Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks associated with minimal symptoms.

Hamer ME, Clair WK, Wilkinson WE, Greenfield RA, Pritchett EL, Page RL.

Pacing Clin Electrophysiol. 1994 May;17(5 Pt 1):938-43.

PMID:
7517528
35.

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL.

Circulation. 1994 Jan;89(1):224-7.

PMID:
8281651
36.

Comparison of mortality in patients treated with propafenone to those treated with a variety of antiarrhythmic drugs for supraventricular arrhythmias.

Pritchett EL, Wilkinson WE, Clair WK, McCarthy EA.

Am J Cardiol. 1993 Jul 1;72(1):108-10. No abstract available.

PMID:
8517417
37.

Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.

Clair WK, Wilkinson WE, McCarthy EA, Page RL, Pritchett EL.

Circulation. 1993 Apr;87(4):1114-22.

PMID:
8462140
38.

The dexamethasone suppression test and quantitative cerebral anatomy in depression.

Coffey CE, Wilkinson WE, Weiner RD, Ritchie JC, Aque M.

Biol Psychiatry. 1993 Mar 15;33(6):442-9.

PMID:
8490071
39.

Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study.

Coffey CE, Wilkinson WE, Weiner RD, Parashos IA, Djang WT, Webb MC, Figiel GS, Spritzer CE.

Arch Gen Psychiatry. 1993 Jan;50(1):7-16.

PMID:
8422224
40.

Medical center studies how consistently workers use gloves to prevent infection.

Wilkinson WE.

Occup Health Saf. 1992 Nov;61(11):35-40, 43, 57. No abstract available.

PMID:
1470430
41.

Occupational injuries: a study of health care workers at a northwestern health science center and teaching hospital.

Wilkinson WE, Salazar MK, Uhl JE, Koepsell TD, DeRoos RL, Long RJ.

AAOHN J. 1992 Jun;40(6):287-93. Erratum in: AAOHN J 1992 Aug;40(8):404.

PMID:
1388372
42.

Treatment of paroxysmal supraventricular tachycardia with oral diltiazem.

Clair WK, Wilkinson WE, McCarthy EA, Pritchett EL.

Clin Pharmacol Ther. 1992 May;51(5):562-5.

PMID:
1587069
43.

Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics.

Page RL, Wharton JM, Wilkinson WE, Friedman IM, Claypool WD, Karim A, Kowalski KG, McDonald SJ, Gardiner P, Pritchett EL.

Clin Pharmacol Ther. 1992 Apr;51(4):371-8.

PMID:
1563207
44.

Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging.

Coffey CE, Wilkinson WE, Parashos IA, Soady SA, Sullivan RJ, Patterson LJ, Figiel GS, Webb MC, Spritzer CE, Djang WT.

Neurology. 1992 Mar;42(3 Pt 1):527-36.

PMID:
1549213
45.

Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study.

Coffey CE, Weiner RD, Djang WT, Figiel GS, Soady SA, Patterson LJ, Holt PD, Spritzer CE, Wilkinson WE.

Arch Gen Psychiatry. 1991 Nov;48(11):1013-21.

PMID:
1747016
46.

New drug application strategies for supraventricular arrhythmias.

Pritchett EL, Wilkinson WE.

Clin Pharmacol Ther. 1991 May;49(5):481-7. No abstract available.

PMID:
2029826
47.

Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.

Pritchett EL, Wilkinson WE.

Am J Cardiol. 1991 May 1;67(11):976-80.

PMID:
1902055
49.

Oral contraceptives and breast cancer: a case-control study with hospital and community controls.

Schildkraut JM, Hulka BS, Wilkinson WE.

Obstet Gynecol. 1990 Sep;76(3 Pt 1):395-402.

PMID:
2381616
50.

MR imaging in patients with temporal lobe seizures: correlation of results with pathologic findings.

Heinz ER, Crain BJ, Radtke RA, Burger PC, Friedman AH, Djang WT, Wilkinson WE.

AJR Am J Roentgenol. 1990 Sep;155(3):581-6.

PMID:
2117360

Supplemental Content

Loading ...
Support Center